Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
Details of activity:
|
Active against Staphylococcus aureus, Streptococcus haemolyticus, Streptococcus pneumoniae, Mycobacterium tuberculosis, Mycobacterium smegmatis, Proteus vulgaris, Shigella flexneri, Salmonella typhosa, Pseudomonas fluorescens Acinetobacter baumannii, and Escherichia coli; inhibits nucleoside diphosphate kinase (in E. coli)
|
Description:
|
Natural product from Streptomyces eridani (also by Streptomyces lavendulocolor or Streptomyces pseudovenezuelae as cyclamidomycin); has pyrroline and acrylamide unit
|
Institute where first reported:
|
Research Laboratories, Gruppo Lepetit S.p.A., Milano, Italy; The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, 2800 Kgs. Lyngby, Denmark
|
Year first mentioned:
|
1971
|
Development status:
|
Experimental
|